Table 2. Univariate models of prognostic factors.
| Factors | No. (%) | Overall survival | ||
|---|---|---|---|---|
| 5-year rate (%) | p-value | |||
| Age (yr) | <0.001 | |||
| ≤40 | 3,307 (23.3) | 81.4 | ||
| ≤50 | 3,241 (22.0) | 76.1 | ||
| ≤60 | 3,284 (23.2) | 70.5 | ||
| ≤70 | 2,416 (17.0) | 70.9 | ||
| >70 | 2,054 (14.5) | 54.7 | ||
| T categories | <0.001 | |||
| T1B | 6,694 (47.2) | 89.3 | ||
| T2 | 4,073 (28.7) | 71.7 | ||
| T3 | 2,542 (17.9) | 47.1 | ||
| T4 | 876 (6.2) | 24.7 | ||
| N categories | <0.001 | |||
| N0 | 10,359 (73.0) | 84.6 | ||
| N1 | 3,826 (27.0) | 53.1 | ||
| M categories | <0.001 | |||
| M0 | 12,743 (89.8) | 78.1 | ||
| M1 | 744 (5.2) | 12.8 | ||
| PAN metastasis | 661 (4.7) | 38.7 | ||
| Unclear | 37 (0.3) | 53.4 | ||
| Histology | <0.001 | |||
| SCC | 10,131 (71.4) | 73.9 | ||
| Adenocarcinoma | 2,831 (20.0) | 71.4 | ||
| Others | 1,223 (8.6) | 66.6 | ||
| 1st treatment | <0.001 | |||
| Surgery | 7,235 (51.0) | 87.6 | ||
| Radiation | 5,055 (35.6) | 57.8 | ||
| Chemo | 1,828 (12.9) | 55.9 | ||
| Others | 67 (0.5) | 44.6 | ||
| Institutions | <0.001 | |||
| Non-JSGO-accredited | 3,256 (23.0) | 69.0 | ||
| JSGO-accredited | 10,920 (77.0) | 73.9 | ||
JSGO, Japan Society of Gynecologic Oncology; M, metastasis; N, node; PAN, para-aortic lymph node; SCC, squamous cell carcinoma; T, tumor.